The effect of alpha-trinositol on cholera toxin-induced hypersecretion and morphological changes in pig jejunum.
alpha-Trinositol (D-myo-inositol 1,2,6-trisphosphate, PP56) is a novel antiinflammatory drug. This study elucidates the effect of intravenous alpha-trinositol on basal and acute fluid transport and morphological changes following cholera toxin administration in pig jejunum in vivo. Using isolated jejunal tied-off loops, the fluid hypersecretory (accumulation) effect of different doses of cholera toxin was studied in pigs treated intravenously with saline added different doses (0, 4, 8, 16 and 32 mg x kg-1 x hr-1) of alpha-trinositol. Levels of alpha-trinositol, as well as stereomicroscopical, light microscopical and scanning electron microscopical morphological studies were performed. Cholera toxin evoked a dose-dependent fluid hypersecretion. Treatment with alpha-trinositol caused a dose-dependent inhibition of the cholera toxin-induced fluid hypersecretion and did not affect basal fluid absorption. The 16 mg x kg-1 x hr-1 alpha-trinositol dose gave a maximal inhibition of 36%. Morphological studies showed only minor changes following 6 hr of exposure to 20 micrograms x loop-1 cholera toxin. These changes consisted of dilation of the villus capillaries, an increase of apical membrane blebbing and a reduction of the intercellular space. Treatment with 16 mg x kg-1 x hr-1 alpha-trinositol alone did not induce any morphological changes, and did not alter the morphological changes induced by cholera toxin, which caused fluid hypersecretion and only minor acute morphological changes. In conclusion, alpha-trinositol treatment reduced cholera toxin-induced fluid hypersecretion without altering basal fluid absorption, basal morphology, or cholera toxin-induced morphological changes in pig jejunum in vivo.
Hansen
M B
MB
Department of Anatomy and Physiology, Royal Veterinary and Agricultural University, Frederiksberg, Denmark.
Tindholdt
T T
TT
Elbrønd
V S
VS
Makinde
M
M
Cassuto
J
J
Beubler
E
E
Westerberg
E J
EJ
Skadhauge
E
E
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D001826:Body Fluids / Q000187:drug effects / Q000378:metabolism / Q000382:microbiology; D002772:Cholera Toxin / Q000494:pharmacology*; D005260:Female; D007275:Injections, Intravenous; D007295:Inositol Phosphates / Q000008:administration & dosage / Q000494:pharmacology*; D007413:Intestinal Mucosa / Q000166:cytology / Q000187:drug effects / Q000648:ultrastructure; D007583:Jejunum / Q000187:drug effects* / Q000378:metabolism* / Q000648:ultrastructure; D008853:Microscopy; D013552:Swine
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007295:Inositol Phosphates; D002772:Cholera Toxin; C059368:atrinositol